Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus

Jimok Kim, Bradley E. Alger

Research output: Contribution to journalArticle

185 Citations (Scopus)

Abstract

In hippocampal pyramidal cells, a rise in Ca2+ releases endocannabinoids that activate the presynaptic cannabinoid receptor (CB1R) and transiently reduce GABAergic transmission-a process called depolarization- induced suppression of inhibition (DSI). The mechanism that limits the duration of endocannabinoid action in intact cells is unknown. Here we show that inhibition of cyclooxygenase-2 (COX-2), not fatty acid amide hydrolase (FAAH), prolongs DSI, suggesting that COX-2 limits endocannabinoid action.

Original languageEnglish (US)
Pages (from-to)697-698
Number of pages2
JournalNature Neuroscience
Volume7
Issue number7
DOIs
StatePublished - Jul 1 2004

Fingerprint

Endocannabinoids
Cyclooxygenase 2
Hippocampus
Presynaptic Receptors
Cannabinoid Receptors
Pyramidal Cells

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. / Kim, Jimok; Alger, Bradley E.

In: Nature Neuroscience, Vol. 7, No. 7, 01.07.2004, p. 697-698.

Research output: Contribution to journalArticle

Kim, Jimok ; Alger, Bradley E. / Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. In: Nature Neuroscience. 2004 ; Vol. 7, No. 7. pp. 697-698.
@article{3b81347c95004bff8c13421a0c6e6adf,
title = "Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus",
abstract = "In hippocampal pyramidal cells, a rise in Ca2+ releases endocannabinoids that activate the presynaptic cannabinoid receptor (CB1R) and transiently reduce GABAergic transmission-a process called depolarization- induced suppression of inhibition (DSI). The mechanism that limits the duration of endocannabinoid action in intact cells is unknown. Here we show that inhibition of cyclooxygenase-2 (COX-2), not fatty acid amide hydrolase (FAAH), prolongs DSI, suggesting that COX-2 limits endocannabinoid action.",
author = "Jimok Kim and Alger, {Bradley E.}",
year = "2004",
month = "7",
day = "1",
doi = "10.1038/nn1262",
language = "English (US)",
volume = "7",
pages = "697--698",
journal = "Nature Neuroscience",
issn = "1097-6256",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus

AU - Kim, Jimok

AU - Alger, Bradley E.

PY - 2004/7/1

Y1 - 2004/7/1

N2 - In hippocampal pyramidal cells, a rise in Ca2+ releases endocannabinoids that activate the presynaptic cannabinoid receptor (CB1R) and transiently reduce GABAergic transmission-a process called depolarization- induced suppression of inhibition (DSI). The mechanism that limits the duration of endocannabinoid action in intact cells is unknown. Here we show that inhibition of cyclooxygenase-2 (COX-2), not fatty acid amide hydrolase (FAAH), prolongs DSI, suggesting that COX-2 limits endocannabinoid action.

AB - In hippocampal pyramidal cells, a rise in Ca2+ releases endocannabinoids that activate the presynaptic cannabinoid receptor (CB1R) and transiently reduce GABAergic transmission-a process called depolarization- induced suppression of inhibition (DSI). The mechanism that limits the duration of endocannabinoid action in intact cells is unknown. Here we show that inhibition of cyclooxygenase-2 (COX-2), not fatty acid amide hydrolase (FAAH), prolongs DSI, suggesting that COX-2 limits endocannabinoid action.

UR - http://www.scopus.com/inward/record.url?scp=3042785976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042785976&partnerID=8YFLogxK

U2 - 10.1038/nn1262

DO - 10.1038/nn1262

M3 - Article

C2 - 15184902

AN - SCOPUS:3042785976

VL - 7

SP - 697

EP - 698

JO - Nature Neuroscience

JF - Nature Neuroscience

SN - 1097-6256

IS - 7

ER -